Saudi Food and Drug Authority Launches Accelerated Review Program for Rare Disease Medicines
Saudi Arabia has introduced a National Accelerated Drug Review program to speed clinical evaluations and market approvals for breakthrough treatments for rare diseases while encouraging international biotechnology companies to conduct trials in the Kingdom.